The focus is on drugs that work on the senses, or on the development and production of sterile eye drops. However, the portfolio also includes drugs that affect the cardiovascular system, blood and blood components, and the digestive system and metabolism.
Production is striving to meet the diverse market demands of technological forms and therapeutic groups, so a wide range of JGL drugs allows doctors to choose the best cure for treating their patient.
Also, by keeping up with global trends and continuously researching our customer needs, we have developed a range of self-treatment products which are, due to their innovative features and quality, aimed at disease prevention and preservation of health, challenged by the contemporary lifestyle.
The popularity of self-treatment is in step with the increasing health trends and awareness of the importance of health. Self-treatment is useful, allowing for a quick solution to ailments not requiring medical assistance, because it reduces the pressure on health institutions, contributing to the rational usage of resources within the health system.
Proper self-treatment requires knowledge of an individual’s body, and a certain amount of information about the illness or symptoms that need treatment, including cooperation with a pharmacist. The non-prescription preparations portfolio covers a wide range of products from the categories of OTC drugs, food supplements, special-purpose cosmetics and cosmetics.
During the process of production, registration and quality control for patient safety, all of the OTC drugs are subject to the same procedure as prescription drugs, to guarantee effectiveness and application safety for patients. OTC drugs are available in pharmacies.